Homepage
Medication Guide
Dosage and Administration of Xphozah (Tenapanor)
Xphozah (Tenapanor) is an FDA-approved sodium-hydrogen exchanger 3 (NHE3) inhibitor specifically indicated for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) undergoi...
511
Monday, November 17th, 2025, 10:55
What Are the Indications for Xphozah (Tenapanor)?
Xphozah (Tenapanor) is an innovative medication approved by the U.S. Food and Drug Administration (FDA), providing a new treatment option for serum phosphorus control in patients with chronic kidney d...
511
Monday, November 17th, 2025, 10:50
Purchase Channels for Xphozah (Tenapanor)
Xphozah (Tenapanor) is a sodium-hydrogen exchanger 3 (NHE3) inhibitor with tenapanor hydrochloride as the active ingredient. First approved in the United States in 2019, this medication is primarily u...
508
Monday, November 17th, 2025, 09:58
Side Effects of Qutenza (Capsaicin Patch)
Qutenza (Capsaicin Patch) is a topical patch system containing 8% capsaicin, indicated for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and diabetic peripheral neurop...
510
Monday, November 17th, 2025, 09:49
What Are the Precautions for Using Qutenza (Capsaicin Patch)?
Qutenza (Capsaicin Patch) is a transdermal drug delivery system containing 8% capsaicin (640 micrograms per square centimeter), which was first approved in the United States in 2009. As a TRPV1 channe...
512
Monday, November 17th, 2025, 09:37
Dosage and Administration of Qutenza (Capsaicin Patch)
Qutenza (Capsaicin Patch) is an FDA-approved topical medication for the treatment of postherpetic neuralgia (PHN) and neuropathic pain associated with diabetic peripheral neuropathy (DPN). Its unique ...
513
Monday, November 17th, 2025, 09:33
What Are the Indications for Qutenza (Capsaicin Patch)?
Qutenza (Capsaicin Patch) is a therapeutic medication approved by the U.S. Food and Drug Administration (FDA), providing an innovative treatment option for patients with specific types of neuropathic ...
510
Monday, November 17th, 2025, 09:28
Purchase Channels for Qutenza (Capsaicin Patch)
Qutenza (Capsaicin Patch) is a topical patch containing 8% capsaicin, classified as a TRPV1 channel agonist. In July 2020, this medication was approved by the U.S. FDA for the treatment of foot neural...
514
Monday, November 17th, 2025, 09:24
What Are the Side Effects of Epalrestat?
Epalrestat is a selective aldose reductase inhibitor. Since its approval in Japan in 1992, it has been mainly used for the treatment of diabetic peripheral neuropathy. Similar to other medications, Ep...
533
Monday, November 17th, 2025, 09:22
What are the Precautions for Taking Epalrestat?
Epalrestat is an aldose reductase inhibitor. Since its approval in Japan in 1992, it has been widely used as an adjuvant treatment for diabetic peripheral neuropathy.What are the Precautions for Takin...
513
Monday, November 17th, 2025, 09:18
69 / 221
2204 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved